$MDLZ

MDLZ Q2 Sales Beat and Higher 2026 Growth View Put Margins in Focus

Mondelez (MDLZ) reported Q2 net revenue of $9.36B (+4.1% YoY), beating estimates. Adjusted EPS of $0.73 also beat. Organic net revenue grew 2.2%. MDLZ raised its 2026 organic net revenue growth outlook to at least 2%. Operating income declined 6.1% due to higher costs. Management maintained 2026 adjusted EPS growth guidance of flat to 5%.

Original reporting
Published Aug 19, 2026, 3:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MDLZ Q2 Sales Beat and Higher 2026 Growth View Put Margins in Focus — source image
Decision brief

The 30-second read

$MDLZNeutralMed
01

Why it matters

The earnings beat may provide short‑term upside, but sustained margin pressure could limit longer‑term rally.

02

Market read

MDLZ's earnings are a key data point for the consumer staples sector and may affect related stocks.

03

What to watch

Raw‑material cost trends and Middle‑East conflict‑related input price volatility could further erode margins.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Mondelez's Q2 results were released on Aug 19, 2026, with a focus on revenue growth and margin challenges.

Company-level read

Ticker impact

$MDLZNeutralHigh confidence
Context

Mondelez International reported Q2 net revenues of $9.355B beating estimates and raised its 2026 organic growth outlook to at least 2%.

Expected impact

Potential modest price gain of 2‑4% in the next few days if investors focus on top‑line beat; downside risk if margin concerns dominate.

Evidence & confidence

Revenue beat is material and new; margin pressure is highlighted, creating mixed trader sentiment.

Market effects

Packaged‑food sector may see broader scrutiny of margin pressures despite sales growth.

Emerging‑market exposure highlighted by strong growth in Asia, Middle East, Africa and Latin America.

Large‑cap consumer staple earnings can influence global consumer‑goods indices.

Counterpoint

Investors could short MDLZ if margin compression worsens, betting on earnings disappointment.

Key entities

  • Mondelez International, Inc.

    Global snack and confectionery manufacturer reporting Q2 results.

Related articles

$MDLZMed

Can Mondelez's Organic Growth Momentum Continue Through 2026?

Mondelez (MDLZ) reported 2.2% organic revenue growth in Q2 2026, driven by volume/mix and pricing. The company raised its full-year outlook to at least 2% growth. Emerging Markets and North America showed strong performance, while Europe lagged due to weather impacts. Shares have risen 15.5% year-to-date, outperforming the industry.

$MDLZMed

Mondelez International, Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Emerging markets delivered robust 4.4% top-line growth, driven by structural distribution expansion rather than cyclical trends, with India and Brazil reaching significant store milestones. North American performance is characterized by a 'K-shaped' recovery where consumers are simultaneously seeking value formats and premium 'better-for-you' options.

$MDLZMed

Is Wall Street Bullish or Bearish on Mondelez International Stock?

Mondelez International (MDLZ) has lagged the S&P 500 over 52 weeks, down 3.8% versus SPX up 16.5%, though YTD it is up 16.4%. The company cited cocoa cost inflation and North America volume weakness. After Q2 2026 results, it rose over 4% on adjusted EPS of $0.73 and revenue of $9.36B, raising FY organic net revenue growth to at least 2%. Analysts expect 2026 adjusted EPS of $3.04. BTIG raised its price target to $73.

$MDLZMedAI 8/10

Mondelez beats second-quarter estimates on steady demand

Mondelez International reported Q2 adjusted profit of 68 cents, beating the 68-cent consensus, and quarterly net revenue of $9.36B versus a $9.20B estimate, helped by steady demand and higher pricing. It raised its annual organic net revenue growth outlook to at least 2%. North America pricing rose 2.2 points; volumes rose 1.2.